escitalopram

(redirected from escitalopram oxalate)
Also found in: Medical.

es·ci·tal·o·pram

 (ĕs′ĭ-tăl′ō-prăm′)
n.
A drug of the SSRI class, C22H21FN2O, that is a stereoisomer of citalopram and is given in the form of its oxalate to treat depression and anxiety.

[es-, isomer pref. (pronunciation spelling of the first letter of S-stereoisomer, isomer with counterclockwise rotation, from Latin sinister, left-handed; see sinister) + citalopram.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

escitalopram

n escitalopram m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
SSRIs include fluoxetine (Prozac), sertraline (Zoloft), escitalopram oxalate (Lexapro), and citalopram (Celexa).
Lundbeck A/S (Lundbeck)(CPH:LUN), a global pharmaceutical company specialised in psychiatric and neurological disorders, announced on Friday that Lexapro (escitalopram oxalate), which is distributed by Mochida Pharmaceutical Co Ltd (Mochida) and Mitsubishi Tanabe Pharma Corporation (Mitsubishi Tanabe) in Japan, is expected to receive a final confirmation of the extension of the eight-year market exclusivity by the Japanese Ministry of Health, Labour and Welfare (MHLW).
In Cece's case, escitalopram oxalate promotes weight gain, and if she is treated for diabetes with a sulfonylurea or thiazolidinedione, she will likely gain more weight.
The researchers disclosed past financial relationships with Forest Laboratories Inc., which markets Lexapro (escitalopram oxalate) and Celexa (citalopram hydrobromide), and with Eli Lilly 8C Co., which markets Prozac (fluoxetine hydrochloride).
The Food and Drug Administration has approved escitalopram oxalate for the treatment of generalized anxiety disorder.
Pharmaceutical company Teva Pharmaceutical Industries Ltd (Nasdaq:TEVA) reported on Wednesday the commercial launch of Escitalopram Oxalate Tablets in the US for the treatment of depression and generalised anxiety disorder.
Lundbeck A/S (Denmark), announced that the Federal District Court, District of Delaware has rescheduled the start of its pending patent litigations trial regarding Lexapro (escitalopram oxalate) from December 5, 2005 to March 15, 2006.